Surgical Treatment of Lung Cancer: Defining Resectability in the Immunotherapy Era

by | Wednesday, 29 January 2025 | Lung Cancer

Thanks to the implementation of neoadjuvant immunotherapy, new horizons have opened up with respect to the limits of surgical tumor resection in patients with lung cancer. However, technical problems need to be addressed, and there is great variability regarding the feasibility of the procedures and the results that can be achieved.

Nuria María Novoa

UNIVERSITY HOSPITAL PUERTA DE HIERRO-MAJADAHONDA, MADRID, SPAIN

Explore More

OncoNews

OncoNews

Lung Icon

Lung Cancer

Uterus Icon

Women's Cancers

Bladder Icon

Urogenital

GI Icon

Gastro-intestinal

Hematology Icon

Hematology

Other Solid Tumor Icon

Other Tumors

Related Posts

Leading Opinions

This article was produced in cooperation with our partners at Leading Opinions Hämatologie & Onkologie, published by Universimed. The original article in its original language can be found via universimed.com and med-diplom.ch.

To continue, please login or sign up first